Rinvoq (upadacitinib)

pCPA File Number: 22379

Negotiation Status:

Concluded with an LOI

Indication(s):

Ankylosing spondylitis

Sponsor/Manufacturer:

AbbVie Corporation

CDA-AMC Project Number:

SR0759-000

pCPA Engagement Letter Issued:

2024-01-31

Negotiation Process Concluded:

2024-04-26